Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Bergmann · SciRah

Researcher profile · Semantic Scholar

A. Bergmann

Share profile

A. Bergmann — researcher profile on SciRah

h-index: 13
Works: 52
Citations: 820

Most-cited papers

Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
S. Simpson-Yap, E. De Brouwer, T. Kalincik, N. Rijke +43 more
2021Neurology215 citations Open access
Semantic Scholar
Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management
J. Bauer, J. Isojärvi, A. Herzog, M. Reuber +11 more
2002Journal of Neurology Neurosurgery & Psychiatry118 citations Open access
Semantic Scholar
COVID-19 in people with multiple sclerosis: A global data sharing initiative
L. Peeters, T. Parciak, C. Walton, L. Geys +44 more
2020Multiple Sclerosis62 citations Open access
Semantic Scholar
Comparative effectiveness of delayed-release dimethyl fumarate versus interferon, glatiramer acetate, teriflunomide, or fingolimod: results from the German NeuroTransData registry
S. Braune, S. Grimm, Philip van Hövell, U. Freudensprung +3 more
2018Journal of Neurology61 citations Open access
Semantic Scholar
Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort
S. Braune, M. Lang, A. Bergmann
2013Journal of Neurology45 citations Open access
Semantic Scholar
Associations of DMT therapies with COVID-19 severity in multiple sclerosis
S. Simpson-Yap, E. De Brouwer, T. Kalincik, N. Rijke +43 more
2021medRxiv33 citations Open access
Semantic Scholar
Efficacy of fingolimod is superior to injectable disease modifying therapies in second-line therapy of relapsing remitting multiple sclerosis
S. Braune, M. Lang, A. Bergmann
2015Journal of Neurology31 citations Open access
Semantic Scholar
Framework for personalized prediction of treatment response in relapsing remitting multiple sclerosis
E. Stühler, S. Braune, F. Lionetto, Y. Heer +4 more
2020BMC Medical Research Methodology30 citations Open access
Semantic Scholar
Neurologist adherence to clinical practice guidelines and costs in patients with newly diagnosed and chronic epilepsy in Germany.
A. Strzelczyk, A. Bergmann, Valeria Biermann, S. Braune +8 more
2016Epilepsy & Behavior27 citations
Semantic Scholar
Updated Results of the COVID-19 in MS Global Data Sharing Initiative
S. Simpson-Yap, A. Pirmani, T. Kalincik, E. De Brouwer +41 more
2022Neurology® Neuroimmunology & Neuroinflammation24 citations Open access
Semantic Scholar
Updated Results of the COVID-19 in MS Global Data Sharing Initiative Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity
S. Simpson-Yap, A. Pirmani, T. Kalincik, E. De Brouwer +41 more
22 citations
Semantic Scholar
Background information on multiple sclerosis patients stopping ongoing immunomodulatory therapy: a multicenter study in a community-based environment
C. Bischoff, H. Schreiber, A. Bergmann
2012Journal of Neurology15 citations
Semantic Scholar
Implementation of a data control framework to ensure confidentiality, integrity, and availability of high-quality real-world data (RWD) in the NeuroTransData (NTD) registry
Knut Wehrle, Viola Tozzi, S. Braune, Fabian Roßnagel +4 more
2022JAMIA Open13 citations Open access
Semantic Scholar
Development of Registry Data to Create Interactive Doctor-Patient Platforms for Personalized Patient Care, Taking the Example of the DESTINY System
A. Bergmann, M. Stangel, M. Weih, Philip van Hövell +3 more
2021Frontiers in Digital Health13 citations Open access
Semantic Scholar
The Multiple Sclerosis Data Alliance Catalogue: Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources.
L. Geys, T. Parciak, A. Pirmani, R. McBurney +40 more
2021International Journal of MS Care12 citations Open access
Semantic Scholar
[Data on multiple sclerosis in Germany and their representation in the ambulatory registry NeuroTransData (NTD) network].
M. Weih, Fabian Roßnagel, Heidi Dikow, Knut Wehrle +2 more
2020Fortschritte der Neurologie Psychiatrie12 citations Open access
Semantic Scholar
Tolerability of tiagabine: a prospective open-label study.
J. Bauer, A. Bergmann, M. Reuber, S. Stodieck +1 more
2002Epileptic disorders11 citations
Semantic Scholar
B-Cell Activity Predicts Response to Glatiramer Acetate and Interferon in Relapsing-Remitting Multiple Sclerosis
S. Tacke, S. Braune, Damiano M. Rovituso, T. Ziemssen +4 more
2021Neurology: Neuroimmunology & Neuroinflammation9 citations Open access
Semantic Scholar
[Recommendations for blood studies and clinical monitoring in early detection of valproate-associated liver failure. Results of a consensus conferences 9 May - 11 May 1997 in Berlin].
S. König, C. Elger, F. Vassella, D. Schmidt +12 more
1998Der Nervenarzt9 citations
Semantic Scholar
Impact of drug diversity on treatment effectiveness in relapsing-remitting multiple sclerosis (RRMS) in Germany between 2010 and 2018: real-world data from the German NeuroTransData multiple sclerosis registry
S. Braune, Fabian Roßnagel, Heidi Dikow, A. Bergmann
2021BMJ Open7 citations Open access
Semantic Scholar
The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry
S. Braune, Sandra Bluemich, Carola Bruns, P. Dirks +111 more
2023BMC Neurology6 citations Open access
Semantic Scholar
Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE Study
G. Castelnovo, O. Gerlach, M. Freedman, A. Bergmann +7 more
2021CNS Drugs6 citations Open access
Semantic Scholar
Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β
S. Simpson-Yap, A. Pirmani, E. De Brouwer, L. Peeters +40 more
2022Multiple Sclerosis and Related Disorders5 citations Open access
Semantic Scholar
PHREND®—A Real-World Data-Driven Tool Supporting Clinical Decisions to Optimize Treatment in Relapsing-Remitting Multiple Sclerosis
S. Braune, E. Stühler, Yanic Heer, Philip van Hoevell +1 more
2022Frontiers in Digital Health4 citations Open access
Semantic Scholar
ECTRIMS 2021 – Late Breaking News Oral Presentations
S. Simpson-Yap, A. Pirmani, E. De Brouwer, L. Geys +34 more
2021Multiple Sclerosis4 citations Open access
Semantic Scholar
Five-year efficacy outcomes of ocrelizumab in relapsing multiple sclerosis: A propensity-matched comparison of the OPERA studies with other disease-modifying therapies in real-world lines of treatments
Erwan Muros-Le Rouzic, Yanic Heer, Sean Yiu, Viola Tozzi +6 more
2024Journal of Central Nervous System Disease3 citations Open access
Semantic Scholar
How do patients with secondary progressive multiple sclerosis enrolled in the EXPAND randomized controlled trial compare with those seen in German clinical practice in the NeuroTransData multiple sclerosis registry?
S. Braune, A. Bergmann, V. Bezlyak, Nicholas Adlard
2022Journal of Central Nervous System Disease3 citations Open access
Semantic Scholar
Patient Preferences In The Choice Of Disease Modifying Drugs For Multiple Sclerosis (P3.137)
A. Bergmann, M. Lang, C. Bischoff, P. Schicklmaier +4 more
2014Neurology3 citations
Semantic Scholar
Overall and patient-specific comparative effectiveness of dimethyl fumarate versus teriflunomide: A novel approach to precision medicine applied to the German NeuroTrans Data Multiple Sclerosis Registry
Xiaotong Jiang, G. Simoneau, Mel Zuercher, Yanic Heer +8 more
2023Multiple Sclerosis Journal - Experimental, Translational and Clinical2 citations Open access
Semantic Scholar
1298Associations of DMT therapies with COVID-19 severity in multiple sclerosis
S. Simpson-Yap, E. De Brouwer, T. Kalincik, N. Rijke +40 more
2021International Journal of Epidemiology2 citations Open access
Semantic Scholar
First insights in real-world effectiveness of erenumab in chronic migraine patients with high burden of disease in Germany from the NTD headache and migraine registry (1760)
Andreas Peikert, Monika Koerwer, Viola Tozzi, Heidi Dikow +4 more
2020Neurology2 citations
Semantic Scholar
PND48 BURDEN OF MULTIPLE SCLEROSIS IN GERMANY — A MATCHED COHORT STUDY USING A LARGE CLAIMS DATABASE
C. König, J. Altevers, C. Maas, D. Meise +8 more
2019Value in Health2 citations Open access
Semantic Scholar
Fatigue, cognition and personality in patients with relapsing-remitting multiple sclerosis (RRMS) - A longitudinal study
C. Lang, M. Lang, P. Flachenecker, H. Meissner +13 more
20112 citations
Semantic Scholar
Persistence to Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis: Results from the German NeuroTransData Registry
S. Braune, P. Dirks, Seya Colloud, Qing Wang +5 more
2025Neurological Therapeutics1 citations Open access
Semantic Scholar
In-vivo B-cell activity predicts response to treatment with glatiramer acetate and interferons in patients with relapsing-remitting multiple sclerosis (RRMS) (1764)
S. Braune, S. Tacke, T. Ziemssen, P. Lehmann +2 more
2020Neurology1 citations
Semantic Scholar
Supporting personalized treatment decisions in relapsing remitting multiple sclerosis (RRMS) (P6.358)
S. Braune, Philip van Hoevell, Sarah Grimm, Anna Drewek +4 more
2018Neurology1 citations
Semantic Scholar
Predicting Disease Activity for Patients with Relapsing Remitting Multiple Sclerosis Using Electronic Medical Records (P1.395)
J. Medin, A. Joyeux, S. Braune, A. Bergmann +2 more
2016Neurology1 citations
Semantic Scholar
Longitudinal Observation of Attentional and Fronto-Temporal Cognitive Functions in Relapsing-Remitting Multiple Sclerosis (RRMS) – 6 Years Follow-Up (S10.003)
H. Schreiber, A. Fuchs, M. Lang, T. Fischer +12 more
2013Neurology1 citations
Semantic Scholar
Fatigue, Kognition und Persönlichkeit bei Patienten mit RRMS
H. Schreiber, K. Kiltz, M. Lang, P. Flachenecker +14 more
2010Der Nervenarzt1 citations
Semantic Scholar
Significance of Valproate in the Therapy for Focal Epilepsies in Adults
G. Krämer, A. Bergmann, C. Elger, H. Lerche +9 more
20071 citations
Semantic Scholar
Updated Results of the COVID-19 in MS Global Data Sharing Initiative Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity
S. Simpson-Yap, A. Pirmani, T. Kalincik, E. De Brouwer +41 more
1 citations
Semantic Scholar
Effectiveness of a digital health application (levidex) on quality of life in people with multiple sclerosis: A pragmatic, randomized controlled trial (LAMONT)
Björn Meyer, Gereon Nelles, Linda T. Betz, A. Bergmann +5 more
2026medRxiv0 citations Open access
Semantic Scholar
EE568 Long-Term Economic Impact of Nonpersistence to Disease-Modifying Therapies in a Cohort of German Patients With Multiple Sclerosis
S. Braune, A. Bergmann, Yanic Heer, J. Jarecki +3 more
2025Value in Health0 citations
Semantic Scholar
Ocrelizumab in Patients With Early-stage RRMS—Results from the Phase IIIb ENSEMBLE Trial and the Matched Real-world NTD MS Registry Cohort (P9-6.005)
H-P. Hartung, T. Holmøy, J. Wuerfel, Yanic Heer +7 more
2024Neurology0 citations
Semantic Scholar
2233 Updated results of the COVID-19 in MS global data sharing initiative: anti-CD20 DMTs deleterious for COVID-19 severity but interferons not protective among people with MS
S. Simpson-Yap, A. Pirmani, T. Kalincik, E. De Brouwer +39 more
2022Abstracts0 citations Open access
Semantic Scholar
Associations of DMT Therapies with COVID-19 Severity in Multiple Sclerosis: An International Cohort Study
S. Simpson-Yap, E. De Brouwer, T. Kalincik, N. Rijke +41 more
2020Social Science Research Network0 citations
Semantic Scholar
Impact of drug diversity on patient care in RRMS in Germany between 2010 and 2018 (1753)
A. Bergmann, S. Braune, Heidi Dikow, Fabian Roßnagel
2020Neurology0 citations
Semantic Scholar
Immunomodulatory therapy in 6427 relapsing-remitting multiple sclerosis (RRMS) patients over time under special consideration of switching to oral DMD: A retrospective data analysis
A. Bergmann, K. Goesswein, S. Braune
2019Journal of Neurological Sciences0 citations
Semantic Scholar
Propensity Score Matched Comparative Effectiveness Analysis of Dimethyl Fumarate Relative to Interferon, Glatiramer Acetate, or Teriflunomide Treated RRMS Outpatients in the German NeuroTransData Registry (P1.351)
A. Bergmann, S. Braune, S. Grimm, Philip van Hövell +2 more
2018Neurology0 citations
Semantic Scholar
Propensity Score Matched Comparative Effectiveness Analysis of Dimethyl Fumarate Relative to Fingolimod-Treated RRMS Outpatients in the German NeuroTransData Registry (P1.373)
S. Braune, Sarah Grimm, Philip van Hövell, Ulrich Freudensprung +2 more
2018Neurology0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Braune×22
Invite
S. Braune — researcher profile on SciRah
S. Braune×16
Invite
S. Braune — researcher profile on SciRah
S. Simpson-Yap×12
Invite
S. Simpson-Yap — researcher profile on SciRah
T. Parciak×12
Invite
T. Parciak — researcher profile on SciRah

×12

Invite

A. Pirmani — researcher profile on SciRah

R. McBurney×12

Invite

R. McBurney — researcher profile on SciRah

Invite

H. Schmidt — researcher profile on SciRah

A. Stahmann×12

Invite

A. Stahmann — researcher profile on SciRah

I. A. van der Mei×12

Invite

I. A. van der Mei — researcher profile on SciRah

E. De Brouwer×11

Invite

E. De Brouwer — researcher profile on SciRah

T. Kalincik×11

Invite

T. Kalincik — researcher profile on SciRah

Invite

T. Spelman — researcher profile on SciRah